Hybrid immunity offers increased protection that is longer-lasting against Covid-19 reinfection, studies show

4 years ago 22

Pfizer/BioNTech's Covid-19 mRNA vaccine provides an added layer of protection against reinfection for people who have been previously infected with Covid-19, as well as increased immune durability over time, according to two studies published Wednesday in the New England Journal of Medicine.